Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines
.jpg)
Daewoong Pharmaceutical Announces Successful Phase 3 Topline Results for New Antidiabetic Drug’s Tri..
Daewoong Pharmaceutical Posts Record Annual Revenue in 2021, with Export Growth of Nabota and New Dr..
Daewoong Pharmaceutical Released Positive Phase 3 Topline Results for New Antidiabetic Drug
